2025-2031 Global Fungal Infection Diagnosis Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Medical Care > 2025-2031 Global Fungal Infection Diagnosis Industry Research & Trends Analysis Report

2025-2031 Global Fungal Infection Diagnosis Industry Research & Trends Analysis Report

Publication Date: 2025-08-15
Report Id: 2363406
Industry: Medical Care
Report Page: 129
Chart: 135

PDF Download

Publication Date: 2025-08-15
Report Id: 2363406
Industry: Medical Care
Report Page: 129
Chart: 135

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Product Overview and Scope of Fungal Infection Diagnosis
1.2 Global Fungal Infection Diagnosis Market Size and Forecast
1.3 China Fungal Infection Diagnosis Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Fungal Infection Diagnosis Share in Global Market, 2020-2031
1.4.2 Fungal Infection Diagnosis Market Size: China VS Global, 2020-2031
1.5 Fungal Infection Diagnosis Market Dynamics
1.5.1 Fungal Infection Diagnosis Market Drivers
1.5.2 Fungal Infection Diagnosis Market Restraints
1.5.3 Fungal Infection Diagnosis Industry Trends
1.5.4 Fungal Infection Diagnosis Industry Policy

2 Competitive Landscape by Company
2.1 Global Fungal Infection Diagnosis Revenue by Company, 2020-2025
2.2 Global Fungal Infection Diagnosis Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Fungal Infection Diagnosis Concentration Ratio
2.4 Global Fungal Infection Diagnosis Mergers & Acquisitions, Expansion Plans
2.5 Global Fungal Infection Diagnosis Manufacturers Product Type
2.6 Global Geographic Distribution of Fungal Infection Diagnosis Companies

3 China Competitive Situation by Company
3.1 China Fungal Infection Diagnosis Revenue by Company, 2020-2025
3.2 China Fungal Infection Diagnosis Fungal Infection Diagnosis Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China Fungal Infection Diagnosis Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)

4 Industry Chain Analysis
4.1 Fungal Infection Diagnosis Industry Chain
4.2 Fungal Infection Diagnosis Upstream Analysis
4.3 Fungal Infection Diagnosis Midstream Analysis
4.4 Fungal Infection Diagnosis Downstream Analysis

5 Sights by Type
5.1 Fungal Infection Diagnosis Classification
5.1.1 Galactomannan Test
5.1.2 (1→3)-β-D Glucan Test
5.2 by Type, Global Fungal Infection Diagnosis Market Size & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Fungal Infection Diagnosis Market Size, 2020-2031

6 Sights by Application
6.1 Fungal Infection Diagnosis Segment by Application
6.1.1 Hospital
6.1.2 Laboratory
6.2 by Application, Global Fungal Infection Diagnosis Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Fungal Infection Diagnosis Market Size, 2020-2031

7 Sights by Region
7.1 By Region, Global Fungal Infection Diagnosis Market Size, 2020 VS 2024 VS 2031
7.2 By Region, Global Fungal Infection Diagnosis Market Size, 2020-2031
7.3 North America
7.3.1 North America Fungal Infection Diagnosis Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Fungal Infection Diagnosis Market Size Market Share
7.4 Europe
7.4.1 Europe Fungal Infection Diagnosis Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Fungal Infection Diagnosis Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Fungal Infection Diagnosis Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Fungal Infection Diagnosis Market Size Market Share
7.6 South America
7.6.1 South America Fungal Infection Diagnosis Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Fungal Infection Diagnosis Market Size Market Share
7.7 Middle East & Africa

8 Sights by Country Level
8.1 By Country, Global Fungal Infection Diagnosis Market Size & CAGR，2020 VS 2024 VS 2031
8.2 By Country, Global Fungal Infection Diagnosis Market Size, 2020-2031
8.3 United States
8.3.1 United States Fungal Infection Diagnosis Market Size, 2020-2031
8.3.2 By Company, United States Fungal Infection Diagnosis Revenue Market Share, 2024
8.3.3 by Type, United States Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.3.4 by Application, United States Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Fungal Infection Diagnosis Market Size, 2020-2031
8.4.2 By Company, Europe Fungal Infection Diagnosis Revenue Market Share, 2024
8.4.3 by Type, Europe Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.4.4 by Application, Europe Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.5 China
8.5.1 China Fungal Infection Diagnosis Market Size, 2020-2031
8.5.2 By Company, China Fungal Infection Diagnosis Revenue Market Share, 2024
8.5.3 by Type, China Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.5.4 by Application, China Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Fungal Infection Diagnosis Market Size, 2020-2031
8.6.2 By Company, Japan Fungal Infection Diagnosis Revenue Market Share, 2024
8.6.3 by Type, Japan Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.6.4 by Application, Japan Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Fungal Infection Diagnosis Market Size, 2020-2031
8.7.2 By Company, South Korea Fungal Infection Diagnosis Revenue Market Share, 2024
8.7.3 by Type, South Korea Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.7.4 by Application, South Korea Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Fungal Infection Diagnosis Market Size, 2020-2031
8.8.2 By Company, Southeast Asia Fungal Infection Diagnosis Revenue Market Share, 2024
8.8.3 by Type, Southeast Asia Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.8.4 by Application, Southeast Asia Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.9 India
8.9.1 India Fungal Infection Diagnosis Market Size, 2020-2031
8.9.2 By Company, India Fungal Infection Diagnosis Revenue Market Share, 2024
8.9.3 by Type, India Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.9.4 by Application, India Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Fungal Infection Diagnosis Market Size, 2020-2031
8.10.2 By Company, Middle East & Africa Fungal Infection Diagnosis Revenue Market Share, 2024
8.10.3 by Type, Middle East & Africa Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031
8.10.4 by Application, Middle East & Africa Fungal Infection Diagnosis Revenue Market Share, 2024 VS 2031

9 Company Profile
9.1 Associates of Cape Cod
9.1.1 Associates of Cape Cod Company Information, Head Office, Market Area, and Industry Position
9.1.2 Associates of Cape Cod Company Profile and Main Business
9.1.3 Associates of Cape Cod Fungal Infection Diagnosis Models, Specifications, and Application
9.1.4 Associates of Cape Cod Fungal Infection Diagnosis Revenue and Gross Margin, 2020-2025
9.1.5 Associates of Cape Cod Recent Developments
9.2 Bio-Rad
9.2.1 Bio-Rad Company Information, Head Office, Market Area, and Industry Position
9.2.2 Bio-Rad Company Profile and Main Business
9.2.3 Bio-Rad Fungal Infection Diagnosis Models, Specifications, and Application
9.2.4 Bio-Rad Fungal Infection Diagnosis Revenue and Gross Margin, 2020-2025
9.2.5 Bio-Rad Recent Developments
9.3 IMMY
9.3.1 IMMY Company Information, Head Office, Market Area, and Industry Position
9.3.2 IMMY Company Profile and Main Business
9.3.3 IMMY Fungal Infection Diagnosis Models, Specifications, and Application
9.3.4 IMMY Fungal Infection Diagnosis Revenue and Gross Margin, 2020-2025
9.3.5 IMMY Recent Developments
9.4 BioMérieux
9.4.1 BioMérieux Company Information, Head Office, Market Area, and Industry Position
9.4.2 BioMérieux Company Profile and Main Business
9.4.3 BioMérieux Fungal Infection Diagnosis Models, Specifications, and Application
9.4.4 BioMérieux Fungal Infection Diagnosis Revenue and Gross Margin, 2020-2025
9.4.5 BioMérieux Recent Developments
9.5 Fujifilm Wako Pure Chemica
9.5.1 Fujifilm Wako Pure Chemica Company Information, Head Office, Market Area, and Industry Position
9.5.2 Fujifilm Wako Pure Chemica Company Profile and Main Business
9.5.3 Fujifilm Wako Pure Chemica Fungal Infection Diagnosis Models, Specifications, and Application
9.5.4 Fujifilm Wako Pure Chemica Fungal Infection Diagnosis Revenue and Gross Margin, 2020-2025
9.5.5 Fujifilm Wako Pure Chemica Recent Developments
9.6 Era Biology
9.6.1 Era Biology Company Information, Head Office, Market Area, and Industry Position
9.6.2 Era Biology Company Profile and Main Business
9.6.3 Era Biology Fungal Infection Diagnosis Models, Specifications, and Application
9.6.4 Era Biology Fungal Infection Diagnosis Revenue and Gross Margin, 2020-2025
9.6.5 Era Biology Recent Developments
9.7 Dynamiker Biotechnology
9.7.1 Dynamiker Biotechnology Company Information, Head Office, Market Area, and Industry Position
9.7.2 Dynamiker Biotechnology Company Profile and Main Business
9.7.3 Dynamiker Biotechnology Fungal Infection Diagnosis Models, Specifications, and Application
9.7.4 Dynamiker Biotechnology Fungal Infection Diagnosis Revenue and Gross Margin, 2020-2025
9.7.5 Dynamiker Biotechnology Recent Developments
9.8 Zhanjiang A&C Biological
9.8.1 Zhanjiang A&C Biological Company Information, Head Office, Market Area, and Industry Position
9.8.2 Zhanjiang A&C Biological Company Profile and Main Business
9.8.3 Zhanjiang A&C Biological Fungal Infection Diagnosis Models, Specifications, and Application
9.8.4 Zhanjiang A&C Biological Fungal Infection Diagnosis Revenue and Gross Margin, 2020-2025
9.8.5 Zhanjiang A&C Biological Recent Developments
9.9 Xiamen Bioendo Technology
9.9.1 Xiamen Bioendo Technology Company Information, Head Office, Market Area, and Industry Position
9.9.2 Xiamen Bioendo Technology Company Profile and Main Business
9.9.3 Xiamen Bioendo Technology Fungal Infection Diagnosis Models, Specifications, and Application
9.9.4 Xiamen Bioendo Technology Fungal Infection Diagnosis Revenue and Gross Margin, 2020-2025
9.9.5 Xiamen Bioendo Technology Recent Developments
9.10 Zhanjiang Bokang Marine Biological
9.10.1 Zhanjiang Bokang Marine Biological Company Information, Head Office, Market Area, and Industry Position
9.10.2 Zhanjiang Bokang Marine Biological Company Profile and Main Business
9.10.3 Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Models, Specifications, and Application
9.10.4 Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Revenue and Gross Margin, 2020-2025
9.10.5 Zhanjiang Bokang Marine Biological Recent Developments
9.11 Fuzhou XinBei Biochemical Industrial
9.11.1 Fuzhou XinBei Biochemical Industrial Company Information, Head Office, Market Area, and Industry Position
9.11.2 Fuzhou XinBei Biochemical Industrial Company Profile and Main Business
9.11.3 Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Models, Specifications, and Application
9.11.4 Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Revenue and Gross Margin, 2020-2025
9.11.5 Fuzhou XinBei Biochemical Industrial Recent Developments
9.12 Zhuhai DL Biotech
9.12.1 Zhuhai DL Biotech Company Information, Head Office, Market Area, and Industry Position
9.12.2 Zhuhai DL Biotech Company Profile and Main Business
9.12.3 Zhuhai DL Biotech Fungal Infection Diagnosis Models, Specifications, and Application
9.12.4 Zhuhai DL Biotech Fungal Infection Diagnosis Revenue and Gross Margin, 2020-2025
9.12.5 Zhuhai DL Biotech Recent Developments
9.13 Autobio Diagnostics
9.13.1 Autobio Diagnostics Company Information, Head Office, Market Area, and Industry Position
9.13.2 Autobio Diagnostics Company Profile and Main Business
9.13.3 Autobio Diagnostics Fungal Infection Diagnosis Models, Specifications, and Application
9.13.4 Autobio Diagnostics Fungal Infection Diagnosis Revenue and Gross Margin, 2020-2025
9.13.5 Autobio Diagnostics Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Fungal Infection Diagnosis should grow from US$ 133 million in 2024 to US$ 286 million by 2031, with a CAGR of 11.8% for the period of 2025-2031.

Invasive fungal disease (IFD) refers to severe infections caused by fungi invading human tissues and bloodstream, leading to tissue damage, organ dysfunction, and inflammatory responses. It is especially prevalent among immunocompromised patients such as organ transplant recipients and cancer patients, with an incidence rate of 20% to 40%, becoming a significant cause of mortality in these populations. To enable early diagnosis and effective treatment, most hospitals worldwide have adopted non-invasive laboratory diagnostic techniques such as the G test and GM test. This report covers the equipment and reagents used for fungal infection diagnosis, specifically focusing on G test and GM test methodologies.

Fungal Infection Diagnosis

According to YH Research, the global market for Fungal Infection Diagnosis should grow from US$ 133 million in 2024 to US$ 286 million by 2031, with a CAGR of 11.8% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Invasive fungal diseases (IFDs) have a high incidence among immunocompromised patients, and early diagnosis remains challenging. Currently, non-invasive laboratory diagnostic techniques such as the G test and GM test are widely used globally for early detection of fungal infections. These methods detect fungal antigens in serum, providing relatively rapid and non-invasive diagnostic options, especially suitable for immunosuppressed patients. However, despite their widespread adoption, these diagnostic methods still have limitations in sensitivity and specificity, and require high technical expertise from operators. Additionally, in some regions, the availability of equipment and reagents is still insufficient, limiting their global accessibility. Therefore, improving the accuracy of diagnostic methods, reducing costs, and expanding their availability worldwide remain pressing issues.With advancements in molecular biology, artificial intelligence, and digital pathology, the field of fungal infection diagnosis is moving towards higher efficiency, precision, and intelligence. For instance, deep learning algorithms have been applied to automatically classify and identify fungal species in microscopic images, enabling rapid and accurate detection without the need for staining, significantly improving diagnostic efficiency and accuracy. Moreover, the establishment of digital pathology image databases provides rich data support for automated detection and classification of fungal infections, promoting research and application in this field. In the future, integrated diagnostic platforms combining artificial intelligence and molecular diagnostic technologies are expected to become mainstream in fungal infection diagnosis, offering more comprehensive, rapid, and accurate diagnostic services.The primary driver for the development of fungal infection diagnostic technologies is the urgent need for early diagnosis and precise treatment. Especially among immunosuppressed patients, early diagnosis and timely treatment are crucial for improving survival rates. However, technological advancements face several barriers. Firstly, the high cost of advanced diagnostic equipment and reagents may limit their application in resource-limited areas. Secondly, the application of artificial intelligence and digital pathology technologies requires large amounts of high-quality data, and the acquisition and sharing of such data face challenges related to privacy protection and ethical issues. Lastly, the promotion and application of these technologies require corresponding training and education to ensure operators can proficiently master new technologies. Therefore, addressing issues such as cost, data sharing, and personnel training will be key to advancing this field.

This report aims to provide a comprehensive study of the global market for Fungal Infection Diagnosis. Report Highlights:
(1) Global Fungal Infection Diagnosis market size (value), history data from 2020-2024, and forecast data from 2025 to 2031.

(2) Global Fungal Infection Diagnosis market competitive situation, revenue, and market share, from 2020 to 2024.

(3) China Fungal Infection Diagnosis market competitive situation, revenue, and market share, from 2020 to 2024.

(4) Global Fungal Infection Diagnosis segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Fungal Infection Diagnosis segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Fungal Infection Diagnosis industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
Galactomannan Test
(1→3)-β-D Glucan Test

Market segment by Application, can be divided into
Hospital
Laboratory

Market segment by players, this report covers
Associates of Cape Cod
Bio-Rad
IMMY
BioMérieux
Fujifilm Wako Pure Chemica
Era Biology
Dynamiker Biotechnology
Zhanjiang A&C Biological
Xiamen Bioendo Technology
Zhanjiang Bokang Marine Biological
Fuzhou XinBei Biochemical Industrial
Zhuhai DL Biotech
Autobio Diagnostics